ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Filamin-a expression in Acute Myeloid Leukemia: a multi-omic analysis of prognostic, metabolic and therapeutic implications (2025)
Cabral, Josana de Moraes Coelho ; Machado Neto, João Agostinho ; Rojas, César Alexander Ortiz ; Rego, Eduardo Magalhães
Conference titles: ASH Annual Meeting and Exposition. Unidades: ICB, FM
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CABRAL, Josana de Moraes Coelho et al. Filamin-a expression in Acute Myeloid Leukemia: a multi-omic analysis of prognostic, metabolic and therapeutic implications. . Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2025-6756. Acesso em: 25 fev. 2026. , 2025
APA
Cabral, J. de M. C., Machado Neto, J. A., Rojas, C. A. O., & Rego, E. M. (2025). Filamin-a expression in Acute Myeloid Leukemia: a multi-omic analysis of prognostic, metabolic and therapeutic implications. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1182/blood-2025-6756
NLM
Cabral J de MC, Machado Neto JA, Rojas CAO, Rego EM. Filamin-a expression in Acute Myeloid Leukemia: a multi-omic analysis of prognostic, metabolic and therapeutic implications [Internet]. 2025 ;[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2025-6756
Vancouver
Cabral J de MC, Machado Neto JA, Rojas CAO, Rego EM. Filamin-a expression in Acute Myeloid Leukemia: a multi-omic analysis of prognostic, metabolic and therapeutic implications [Internet]. 2025 ;[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2025-6756
Trabalho de evento-resumo periodico
Metabolic reprogramming drives acquired venetoclax resistance in Acute Myeloid Leukemia and reveals targetable vulnerabilities (2025)
Lima, Keli Cristina de ; Queiroz, Gustavo Nery de ; Cipelli, Marcella ; Tomaz, Victória ; Cortes, Luiz Gustavo Ferreira ; Silva, Marina Basto; Guedes, Rafael; Campregher, Paulo Vidal ; Câmara, Niels Olsen Saraiva ; Costa-Lotufo, Letícia Veras ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidades: ICB, FM
Subjects: FARMCACOLOGIA, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. Metabolic reprogramming drives acquired venetoclax resistance in Acute Myeloid Leukemia and reveals targetable vulnerabilities. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2025-6785. Acesso em: 25 fev. 2026. , 2025
APA
Lima, K. C. de, Queiroz, G. N. de, Cipelli, M., Tomaz, V., Cortes, L. G. F., Silva, M. B., et al. (2025). Metabolic reprogramming drives acquired venetoclax resistance in Acute Myeloid Leukemia and reveals targetable vulnerabilities. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1182/blood-2025-6785
NLM
Lima KC de, Queiroz GN de, Cipelli M, Tomaz V, Cortes LGF, Silva MB, Guedes R, Campregher PV, Câmara NOS, Costa-Lotufo LV, Rego EM, Machado Neto JA. Metabolic reprogramming drives acquired venetoclax resistance in Acute Myeloid Leukemia and reveals targetable vulnerabilities [Internet]. Blood. 2025 ; 146 6785.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2025-6785
Vancouver
Lima KC de, Queiroz GN de, Cipelli M, Tomaz V, Cortes LGF, Silva MB, Guedes R, Campregher PV, Câmara NOS, Costa-Lotufo LV, Rego EM, Machado Neto JA. Metabolic reprogramming drives acquired venetoclax resistance in Acute Myeloid Leukemia and reveals targetable vulnerabilities [Internet]. Blood. 2025 ; 146 6785.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2025-6785
Trabalho de evento-resumo periodico
Clinical validation of automated manufacture of autologous CD19 CAR-T cells for treatment of B neoplasia (2022)
Kerbauy, Lucila; Okamoto, Oswaldo Keith
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidade: IB
Subjects: CÉLULAS, VETORES, CULTURA DE CÉLULAS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KERBAUY, Lucila e OKAMOTO, Oswaldo Keith. Clinical validation of automated manufacture of autologous CD19 CAR-T cells for treatment of B neoplasia. Blood. Washington: Instituto de Biociências, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2022-170045. Acesso em: 25 fev. 2026. , 2022
APA
Kerbauy, L., & Okamoto, O. K. (2022). Clinical validation of automated manufacture of autologous CD19 CAR-T cells for treatment of B neoplasia. Blood. Washington: Instituto de Biociências, Universidade de São Paulo. doi:10.1182/blood-2022-170045
NLM
Kerbauy L, Okamoto OK. Clinical validation of automated manufacture of autologous CD19 CAR-T cells for treatment of B neoplasia [Internet]. Blood. 2022 ; 40( 1):[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2022-170045
Vancouver
Kerbauy L, Okamoto OK. Clinical validation of automated manufacture of autologous CD19 CAR-T cells for treatment of B neoplasia [Internet]. Blood. 2022 ; 40( 1):[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2022-170045
Trabalho de evento-resumo periodico
M2 macrophages drive resistance to phagocytosis and improve mitochondrial metabolism in acute myeloid leukemia facilitating leukemic transformation and in vivo engraftment (2022)
Weinhaeuser, Isabel; Pereira-Martins, Diego Antonio; Almeida, Luciana Yamamoto de ; Hilberink, Jacobien R.; Silveira, Douglas Rafaele Almeida ; Quek, Lynn; Ortiz, César Alexander; Lucena-Araújo, Antonio Roberto; Araujo, Cleide L.; Bianco, Thiago Mantello ; Mota, Jose Mauricio; Hogeling, Shanna M.; Sternadt, Dominique; Diepstra, Arjan; Visser, Nienke; Ammatuna, Emanuele; Huls, Gerwin A.; Rego, Eduardo Magalhães ; Schuringa, Jan Jacob
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidades: FM, FMRP
Subjects: MACRÓFAGOS, FAGOCITOSE, LEUCEMIA MIELOIDE AGUDA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WEINHAEUSER, Isabel et al. M2 macrophages drive resistance to phagocytosis and improve mitochondrial metabolism in acute myeloid leukemia facilitating leukemic transformation and in vivo engraftment. Blood. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2022-165130. Acesso em: 25 fev. 2026. , 2022
APA
Weinhaeuser, I., Pereira-Martins, D. A., Almeida, L. Y. de, Hilberink, J. R., Silveira, D. R. A., Quek, L., et al. (2022). M2 macrophages drive resistance to phagocytosis and improve mitochondrial metabolism in acute myeloid leukemia facilitating leukemic transformation and in vivo engraftment. Blood. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1182/blood-2022-165130
NLM
Weinhaeuser I, Pereira-Martins DA, Almeida LY de, Hilberink JR, Silveira DRA, Quek L, Ortiz CA, Lucena-Araújo AR, Araujo CL, Bianco TM, Mota JM, Hogeling SM, Sternadt D, Diepstra A, Visser N, Ammatuna E, Huls GA, Rego EM, Schuringa JJ. M2 macrophages drive resistance to phagocytosis and improve mitochondrial metabolism in acute myeloid leukemia facilitating leukemic transformation and in vivo engraftment [Internet]. Blood. 2022 ; 140( suppl. 1): 1259-1260.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2022-165130
Vancouver
Weinhaeuser I, Pereira-Martins DA, Almeida LY de, Hilberink JR, Silveira DRA, Quek L, Ortiz CA, Lucena-Araújo AR, Araujo CL, Bianco TM, Mota JM, Hogeling SM, Sternadt D, Diepstra A, Visser N, Ammatuna E, Huls GA, Rego EM, Schuringa JJ. M2 macrophages drive resistance to phagocytosis and improve mitochondrial metabolism in acute myeloid leukemia facilitating leukemic transformation and in vivo engraftment [Internet]. Blood. 2022 ; 140( suppl. 1): 1259-1260.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2022-165130
Trabalho de evento-resumo periodico
Immune dysregulation in human telomere diseases (2022)
Gomes, Willian Robert; Carvalho, Vinícius Silva de; Santana, Bárbara Amélia Aparecida; Martinez, Edson Zangiacomi ; Ramalho, Leandra Naíra Zambelli; Condino Neto, Antonio; Rodrigues, Rodrigo do Tocantins Calado de Saloma
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidades: FMRP, ICB
Subjects: IMUNOLOGIA, TELÔMERO, BIOMARCADORES, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Willian Robert et al. Immune dysregulation in human telomere diseases. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2022-169926. Acesso em: 25 fev. 2026. , 2022
APA
Gomes, W. R., Carvalho, V. S. de, Santana, B. A. A., Martinez, E. Z., Ramalho, L. N. Z., Condino Neto, A., & Rodrigues, R. do T. C. de S. (2022). Immune dysregulation in human telomere diseases. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2022-169926
NLM
Gomes WR, Carvalho VS de, Santana BAA, Martinez EZ, Ramalho LNZ, Condino Neto A, Rodrigues R do TC de S. Immune dysregulation in human telomere diseases [Internet]. Blood. 2022 ; 140 8668-8670.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2022-169926
Vancouver
Gomes WR, Carvalho VS de, Santana BAA, Martinez EZ, Ramalho LNZ, Condino Neto A, Rodrigues R do TC de S. Immune dysregulation in human telomere diseases [Internet]. Blood. 2022 ; 140 8668-8670.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2022-169926
Trabalho de evento-resumo periodico
Metformin inhibits STAT3 and MAPK signaling through AMPK activation in CSF3RT618I cells (2022)
Fonseca, Natasha Peixoto ; Fenerich, Bruna Alves ; Pereira-Martins, Diego Antonio; Garibaldi, Pedro Manoel Marques; Coelho-Silva, Juan Luiz ; Silva, Antônio Bruno Alves; Fernandes, Jaqueline Cristina; Silva, Cleide Lúcia Araújo; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho ; Traina, Fabiola
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidades: FM, ICB, FMRP
Subjects: METFORMINA, LEUCEMIA, MARCADOR MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Natasha Peixoto et al. Metformin inhibits STAT3 and MAPK signaling through AMPK activation in CSF3RT618I cells. Blood. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2022-167392. Acesso em: 25 fev. 2026. , 2022
APA
Fonseca, N. P., Fenerich, B. A., Pereira-Martins, D. A., Garibaldi, P. M. M., Coelho-Silva, J. L., Silva, A. B. A., et al. (2022). Metformin inhibits STAT3 and MAPK signaling through AMPK activation in CSF3RT618I cells. Blood. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1182/blood-2022-167392
NLM
Fonseca NP, Fenerich BA, Pereira-Martins DA, Garibaldi PMM, Coelho-Silva JL, Silva ABA, Fernandes JC, Silva CLA, Rego EM, Machado Neto JA, Traina F. Metformin inhibits STAT3 and MAPK signaling through AMPK activation in CSF3RT618I cells [Internet]. Blood. 2022 ; 140( suppl. 1): 12153-12154.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2022-167392
Vancouver
Fonseca NP, Fenerich BA, Pereira-Martins DA, Garibaldi PMM, Coelho-Silva JL, Silva ABA, Fernandes JC, Silva CLA, Rego EM, Machado Neto JA, Traina F. Metformin inhibits STAT3 and MAPK signaling through AMPK activation in CSF3RT618I cells [Internet]. Blood. 2022 ; 140( suppl. 1): 12153-12154.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2022-167392
Trabalho de evento-resumo periodico
Molecular characterization of clinical response and relapse in patients with IDH1m ND-AML treated with Ivo+AZA in the aGILE study (2022)
Döhner, Hartmut; Marchione, Dylan M.; Choe, Sung; Montesinos, Pau; Recher, Christian; Vives, Susana; Zarzycka, Ewa; Wang, Jianxiang; Cerchione, Claudio; Heuser, Michael; Calado, Rodrigo Tocantins ; Schuh, Andre C.; Yeh, Su-Peng; De La Fuente, Adolfo; Hui, Jianan; Patel, Prapti; Gianolio, Diego; Daigle, Scott R.; DiNardo, Courtney D.; Botton, Stephane de
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidade: FMRP
Assunto: MOLÉCULA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DÖHNER, Hartmut et al. Molecular characterization of clinical response and relapse in patients with IDH1m ND-AML treated with Ivo+AZA in the aGILE study. Blood. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2022-159473. Acesso em: 25 fev. 2026. , 2022
APA
Döhner, H., Marchione, D. M., Choe, S., Montesinos, P., Recher, C., Vives, S., et al. (2022). Molecular characterization of clinical response and relapse in patients with IDH1m ND-AML treated with Ivo+AZA in the aGILE study. Blood. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2022-159473
NLM
Döhner H, Marchione DM, Choe S, Montesinos P, Recher C, Vives S, Zarzycka E, Wang J, Cerchione C, Heuser M, Calado RT, Schuh AC, Yeh S-P, De La Fuente A, Hui J, Patel P, Gianolio D, Daigle SR, DiNardo CD, Botton S de. Molecular characterization of clinical response and relapse in patients with IDH1m ND-AML treated with Ivo+AZA in the aGILE study [Internet]. Blood. 2022 ; 140( suppl. 1): 539-542.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2022-159473
Vancouver
Döhner H, Marchione DM, Choe S, Montesinos P, Recher C, Vives S, Zarzycka E, Wang J, Cerchione C, Heuser M, Calado RT, Schuh AC, Yeh S-P, De La Fuente A, Hui J, Patel P, Gianolio D, Daigle SR, DiNardo CD, Botton S de. Molecular characterization of clinical response and relapse in patients with IDH1m ND-AML treated with Ivo+AZA in the aGILE study [Internet]. Blood. 2022 ; 140( suppl. 1): 539-542.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2022-159473
Trabalho de evento-resumo periodico
Molecular international prognostic Scoring System (IPSS-M) in myelodysplastic syndromes arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria (2022)
Gurnari, Carmelo; Prata, Pedro H.; Catto, Luiz Fernando Bazzo ; Durmaz, Arda; Larcher, Lise; Sebert, Marie; Allain, Vincent; Kewan, Tariq; Pagliuca, Simona; Pinto, André Luiz; Inacio, Mariana Carolina Beraldo; Hernandez, Lucie; Dhedin, Nathalie; Caillat-Zucman, Sophie; Clappier, Emmanuelle; Fontbrune, Flore Sicre de; Voso, Maria Teresa; Visconte, Valeria; Peffault de Latour, Regis; Soulier, Jean; Socie, Gerard; Calado, Rodrigo Tocantins ; Maciejewski, Jaroslaw P.
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidade: FMRP
Subjects: ANEMIA, LEUCEMIA MIELOIDE, CITOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GURNARI, Carmelo et al. Molecular international prognostic Scoring System (IPSS-M) in myelodysplastic syndromes arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria. Blood. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2022-160458. Acesso em: 25 fev. 2026. , 2022
APA
Gurnari, C., Prata, P. H., Catto, L. F. B., Durmaz, A., Larcher, L., Sebert, M., et al. (2022). Molecular international prognostic Scoring System (IPSS-M) in myelodysplastic syndromes arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria. Blood. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2022-160458
NLM
Gurnari C, Prata PH, Catto LFB, Durmaz A, Larcher L, Sebert M, Allain V, Kewan T, Pagliuca S, Pinto AL, Inacio MCB, Hernandez L, Dhedin N, Caillat-Zucman S, Clappier E, Fontbrune FS de, Voso MT, Visconte V, Peffault de Latour R, Soulier J, Socie G, Calado RT, Maciejewski JP. Molecular international prognostic Scoring System (IPSS-M) in myelodysplastic syndromes arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Internet]. Blood. 2022 ; 140( suppl. 1): 5788-5789.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2022-160458
Vancouver
Gurnari C, Prata PH, Catto LFB, Durmaz A, Larcher L, Sebert M, Allain V, Kewan T, Pagliuca S, Pinto AL, Inacio MCB, Hernandez L, Dhedin N, Caillat-Zucman S, Clappier E, Fontbrune FS de, Voso MT, Visconte V, Peffault de Latour R, Soulier J, Socie G, Calado RT, Maciejewski JP. Molecular international prognostic Scoring System (IPSS-M) in myelodysplastic syndromes arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Internet]. Blood. 2022 ; 140( suppl. 1): 5788-5789.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2022-160458
Trabalho de evento-resumo periodico
Sickle cell disease mortality in Brazil: real-world evidence (2021)
Cançado, Rodolfo D; Costa, Fernando Ferreira; Lobo, Clarisse; Migliavaca, Celina Borges; Falavigna, Maicon; Souza Filho, Homero C. R.; Bueno, Carolina Tosin; Pinto, Ana Cristina Silva
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidade: FMRP
Subjects: DOENÇAS GENÉTICAS, DOENÇAS HEREDITÁRIAS, MUTAÇÃO GENÉTICA, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANÇADO, Rodolfo D et al. Sickle cell disease mortality in Brazil: real-world evidence. Blood. Atlanta: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-151098. Acesso em: 25 fev. 2026. , 2021
APA
Cançado, R. D., Costa, F. F., Lobo, C., Migliavaca, C. B., Falavigna, M., Souza Filho, H. C. R., et al. (2021). Sickle cell disease mortality in Brazil: real-world evidence. Blood. Atlanta: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-151098
NLM
Cançado RD, Costa FF, Lobo C, Migliavaca CB, Falavigna M, Souza Filho HCR, Bueno CT, Pinto ACS. Sickle cell disease mortality in Brazil: real-world evidence [Internet]. Blood. 2021 ; 138 3025.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2021-151098
Vancouver
Cançado RD, Costa FF, Lobo C, Migliavaca CB, Falavigna M, Souza Filho HCR, Bueno CT, Pinto ACS. Sickle cell disease mortality in Brazil: real-world evidence [Internet]. Blood. 2021 ; 138 3025.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2021-151098
Trabalho de evento-resumo periodico
Tumor associated macrophages promoted fatal patient derived acute promyelocytic leukemia in vivo (2021)
Weinhäuser, Isabel ; Martins, Diego A. Pereira; Hilberink, Jacobien R.; Almeida, Luciana Yamamoto de ; Silveira, Douglas Rafaele Almeida ; Quek, Lynn; Hogeling, Shanna M.; Mota, Jose Mauricio; Ammatuna, Emanuele; Araujo, Antônio Roberto Lucena de ; Huls, Gerwin A.; Schuringa, Jan Jacob; Rego, Eduardo Magalhães
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidades: FM, FMRP
Subjects: MACRÓFAGOS, TUMOR CARCINOIDE, MARCADOR MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WEINHÄUSER, Isabel et al. Tumor associated macrophages promoted fatal patient derived acute promyelocytic leukemia in vivo. Blood. Atlanta: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-150699. Acesso em: 25 fev. 2026. , 2021
APA
Weinhäuser, I., Martins, D. A. P., Hilberink, J. R., Almeida, L. Y. de, Silveira, D. R. A., Quek, L., et al. (2021). Tumor associated macrophages promoted fatal patient derived acute promyelocytic leukemia in vivo. Blood. Atlanta: Faculdade de Medicina, Universidade de São Paulo. doi:10.1182/blood-2021-150699
NLM
Weinhäuser I, Martins DAP, Hilberink JR, Almeida LY de, Silveira DRA, Quek L, Hogeling SM, Mota JM, Ammatuna E, Araujo ARL de, Huls GA, Schuringa JJ, Rego EM. Tumor associated macrophages promoted fatal patient derived acute promyelocytic leukemia in vivo [Internet]. Blood. 2021 ; 138 3472.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2021-150699
Vancouver
Weinhäuser I, Martins DAP, Hilberink JR, Almeida LY de, Silveira DRA, Quek L, Hogeling SM, Mota JM, Ammatuna E, Araujo ARL de, Huls GA, Schuringa JJ, Rego EM. Tumor associated macrophages promoted fatal patient derived acute promyelocytic leukemia in vivo [Internet]. Blood. 2021 ; 138 3472.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2021-150699
Trabalho de evento-resumo periodico
COVID-19 incidence in asymptomatic cancer patients undergoing chemotherapy (2021)
Monteiro, Claudia Mota Leite Barbosa; Gomes, Cecilia; Marani, Leticia Olops ; Colli, Leandro Machado ; Calado, Rodrigo Tocantins ; Figueiredo-Pontes, Lorena Lobo
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidade: FMRP
Subjects: COVID-19, PNEUMOPATIAS, HIPERTENSÃO, DOENÇA CRÔNICA, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTEIRO, Claudia Mota Leite Barbosa et al. COVID-19 incidence in asymptomatic cancer patients undergoing chemotherapy. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-151772. Acesso em: 25 fev. 2026. , 2021
APA
Monteiro, C. M. L. B., Gomes, C., Marani, L. O., Colli, L. M., Calado, R. T., & Figueiredo-Pontes, L. L. (2021). COVID-19 incidence in asymptomatic cancer patients undergoing chemotherapy. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-151772
NLM
Monteiro CMLB, Gomes C, Marani LO, Colli LM, Calado RT, Figueiredo-Pontes LL. COVID-19 incidence in asymptomatic cancer patients undergoing chemotherapy [Internet]. Blood. 2021 ; 138 4972.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2021-151772
Vancouver
Monteiro CMLB, Gomes C, Marani LO, Colli LM, Calado RT, Figueiredo-Pontes LL. COVID-19 incidence in asymptomatic cancer patients undergoing chemotherapy [Internet]. Blood. 2021 ; 138 4972.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2021-151772
Trabalho de evento-resumo periodico
Viability of Chimeric Antigen Receptor T Cell Therapy in Latin America (2021)
Cunha, Renato Luiz Guerino ; Clé, Diego Villa ; Palma, Leonardo Carvalho ; Donadel, Camila Derminio ; Oliveira, Lucas; Terra, Patrícia Oliveira da Cunha; Costa, Thalita Cristina de Mello; Dias, Juliana Bernardes Elias; Pieroni, Fabiano; Stracieri, Ana Beatriz Pereira Lima; Silveira, Caio Raony Farina ; Puga, Marcelo Lourencini; Martins, Amanda Posselt ; Caruso, Sâmia Rigotto; Souza, Lucas Eduardo Botelho de ; Fantacini, Daianne Maciely Carvalho ; Barboza, Leticia Maria Defendi; Giuberti, Maria Fernanda Lima; Pereira, Gabriel de Carvalho; Fernandes, Taisa Risque; Bolzoni, Rosane Maria Falasco; Vieira, Ana Carolina Jesus; Palma, Patricia Vianna Bonini ; Basile-Filho, Anibal ; Chahud, Fernando ; Prado Júnior, Benedito de Pina Almeida; Orellana, Maristela Delgado ; Santis, Gil Cunha De ; Rego, Eduardo Magalhães ; Calado, Rodrigo Tocantins ; Covas, Dimas Tadeu
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidades: FMRP, FM
Subjects: CÉLULAS-TRONCO, ANTÍGENOS, LINFOMA, ONCOLOGIA, AMÉRICA LATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUNHA, Renato Luiz Guerino et al. Viability of Chimeric Antigen Receptor T Cell Therapy in Latin America. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-154217. Acesso em: 25 fev. 2026. , 2021
APA
Cunha, R. L. G., Clé, D. V., Palma, L. C., Donadel, C. D., Oliveira, L., Terra, P. O. da C., et al. (2021). Viability of Chimeric Antigen Receptor T Cell Therapy in Latin America. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-154217
NLM
Cunha RLG, Clé DV, Palma LC, Donadel CD, Oliveira L, Terra PO da C, Costa TC de M, Dias JBE, Pieroni F, Stracieri ABPL, Silveira CRF, Puga ML, Martins AP, Caruso SR, Souza LEB de, Fantacini DMC, Barboza LMD, Giuberti MFL, Pereira G de C, Fernandes TR, Bolzoni RMF, Vieira ACJ, Palma PVB, Basile-Filho A, Chahud F, Prado Júnior B de PA, Orellana MD, Santis GCD, Rego EM, Calado RT, Covas DT. Viability of Chimeric Antigen Receptor T Cell Therapy in Latin America [Internet]. Blood. 2021 ; 138 4843.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2021-154217
Vancouver
Cunha RLG, Clé DV, Palma LC, Donadel CD, Oliveira L, Terra PO da C, Costa TC de M, Dias JBE, Pieroni F, Stracieri ABPL, Silveira CRF, Puga ML, Martins AP, Caruso SR, Souza LEB de, Fantacini DMC, Barboza LMD, Giuberti MFL, Pereira G de C, Fernandes TR, Bolzoni RMF, Vieira ACJ, Palma PVB, Basile-Filho A, Chahud F, Prado Júnior B de PA, Orellana MD, Santis GCD, Rego EM, Calado RT, Covas DT. Viability of Chimeric Antigen Receptor T Cell Therapy in Latin America [Internet]. Blood. 2021 ; 138 4843.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2021-154217
Trabalho de evento-resumo periodico
Umbilical cord blood transplantation after graft failure from a previous hematopoietic stem cell transplantation (2021)
Volt, Fernanda; Ruggeri, Annalisa; Scigliuolo, Graziana Maria; Latour, Régis Peffault de; Bierings, Marc; Al-seraihy, Amal; Bittencourt, Henrique; Labussiere-wallet, Helene; Rocha, Vanderson Geraldo ; Kenzey, Chantal; Cappelli, Barbara; Rafii, Hanadi; Gluckman, Eliane; Cunha, Renato Luiz Guerino
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidades: FM, FMRP
Subjects: TRANSPLANTE DE ÓRGÃOS, CÉLULAS-TRONCO, CORDÃO UMBILICAL, DOENÇA ENXERTO-HOSPEDEIRO, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VOLT, Fernanda et al. Umbilical cord blood transplantation after graft failure from a previous hematopoietic stem cell transplantation. Blood. Washington: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-145287. Acesso em: 25 fev. 2026. , 2021
APA
Volt, F., Ruggeri, A., Scigliuolo, G. M., Latour, R. P. de, Bierings, M., Al-seraihy, A., et al. (2021). Umbilical cord blood transplantation after graft failure from a previous hematopoietic stem cell transplantation. Blood. Washington: Faculdade de Medicina, Universidade de São Paulo. doi:10.1182/blood-2021-145287
NLM
Volt F, Ruggeri A, Scigliuolo GM, Latour RP de, Bierings M, Al-seraihy A, Bittencourt H, Labussiere-wallet H, Rocha VG, Kenzey C, Cappelli B, Rafii H, Gluckman E, Cunha RLG. Umbilical cord blood transplantation after graft failure from a previous hematopoietic stem cell transplantation [Internet]. Blood. 2021 ; 138( suppl. 1):[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2021-145287
Vancouver
Volt F, Ruggeri A, Scigliuolo GM, Latour RP de, Bierings M, Al-seraihy A, Bittencourt H, Labussiere-wallet H, Rocha VG, Kenzey C, Cappelli B, Rafii H, Gluckman E, Cunha RLG. Umbilical cord blood transplantation after graft failure from a previous hematopoietic stem cell transplantation [Internet]. Blood. 2021 ; 138( suppl. 1):[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2021-145287
Trabalho de evento-resumo periodico
Irs1S57X heterozygous mutant mice display normal hematopoiesis and phenotypic features, while homozygous knockout exhibit high fetal or postnatal lethality (2020)
Fenerich, Bruna Alves ; Fernandes, Jaqueline Cristina; Silva, Cleide Lúcia Araújo; Coelho-Silva, Juan Luiz; Silva, Antônio Bruno Alves; Fonseca, Natasha Peixoto; Machado Neto, João Agostinho ; Traina, Fabiola
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidades: ICB, FMRP
Subjects: HEMATOPOESE, TRANSTORNOS MIELOPROLIFERATIVOS, NEOPLASIAS, GENES, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FENERICH, Bruna Alves et al. Irs1S57X heterozygous mutant mice display normal hematopoiesis and phenotypic features, while homozygous knockout exhibit high fetal or postnatal lethality. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2020-139422. Acesso em: 25 fev. 2026. , 2020
APA
Fenerich, B. A., Fernandes, J. C., Silva, C. L. A., Coelho-Silva, J. L., Silva, A. B. A., Fonseca, N. P., et al. (2020). Irs1S57X heterozygous mutant mice display normal hematopoiesis and phenotypic features, while homozygous knockout exhibit high fetal or postnatal lethality. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1182/blood-2020-139422
NLM
Fenerich BA, Fernandes JC, Silva CLA, Coelho-Silva JL, Silva ABA, Fonseca NP, Machado Neto JA, Traina F. Irs1S57X heterozygous mutant mice display normal hematopoiesis and phenotypic features, while homozygous knockout exhibit high fetal or postnatal lethality [Internet]. Blood. 2020 ; 136 [3] .[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2020-139422
Vancouver
Fenerich BA, Fernandes JC, Silva CLA, Coelho-Silva JL, Silva ABA, Fonseca NP, Machado Neto JA, Traina F. Irs1S57X heterozygous mutant mice display normal hematopoiesis and phenotypic features, while homozygous knockout exhibit high fetal or postnatal lethality [Internet]. Blood. 2020 ; 136 [3] .[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2020-139422
Trabalho de evento-resumo periodico
Eltrombopag specifically expands hematopoietic multipotent progenitors in human aplastic anemia (2020)
Oliveira, Bruno Quintino; Santana, Bárbara; Catto, Luiz Fernando Bazzo ; Tellechea, Maria Florencia; Scheucher, Priscila Santos; Scheinberg, Phillip; Calado, Rodrigo Tocantins
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidade: FMRP
Subjects: ANEMIA, HEMATOPOESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Bruno Quintino et al. Eltrombopag specifically expands hematopoietic multipotent progenitors in human aplastic anemia. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2020-142746. Acesso em: 25 fev. 2026. , 2020
APA
Oliveira, B. Q., Santana, B., Catto, L. F. B., Tellechea, M. F., Scheucher, P. S., Scheinberg, P., & Calado, R. T. (2020). Eltrombopag specifically expands hematopoietic multipotent progenitors in human aplastic anemia. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2020-142746
NLM
Oliveira BQ, Santana B, Catto LFB, Tellechea MF, Scheucher PS, Scheinberg P, Calado RT. Eltrombopag specifically expands hematopoietic multipotent progenitors in human aplastic anemia [Internet]. Blood. 2020 ; 136 [3] .[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2020-142746
Vancouver
Oliveira BQ, Santana B, Catto LFB, Tellechea MF, Scheucher PS, Scheinberg P, Calado RT. Eltrombopag specifically expands hematopoietic multipotent progenitors in human aplastic anemia [Internet]. Blood. 2020 ; 136 [3] .[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2020-142746
Trabalho de evento-resumo periodico
The role of plasmin/plasminogen in experimental polymicrobial sepsis (2020)
Vago, Juliana; Brito, Larissa Froede; Teixeira, Lívia C. R.; Moreira, Izabela Z.; Miranda, Thaís C.; Melo, Eliza M.; Bruno, Alexandre S.; Sugimoto, Michelle A.; Ferreira, Raphael G.; Alves Filho, José Carlos Farias ; Teixeira, Mauro M.; Parmer, Robert J; Miles, Lindsey A.; Sousa, Lirlandia P.
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidade: FMRP
Subjects: SEPSE, MORTALIDADE, NEUTRÓFILOS, ENZIMAS, SANGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VAGO, Juliana et al. The role of plasmin/plasminogen in experimental polymicrobial sepsis. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2020-139180. Acesso em: 25 fev. 2026. , 2020
APA
Vago, J., Brito, L. F., Teixeira, L. C. R., Moreira, I. Z., Miranda, T. C., Melo, E. M., et al. (2020). The role of plasmin/plasminogen in experimental polymicrobial sepsis. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2020-139180
NLM
Vago J, Brito LF, Teixeira LCR, Moreira IZ, Miranda TC, Melo EM, Bruno AS, Sugimoto MA, Ferreira RG, Alves Filho JCF, Teixeira MM, Parmer RJ, Miles LA, Sousa LP. The role of plasmin/plasminogen in experimental polymicrobial sepsis [Internet]. Blood. 2020 ; 136 16-17.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2020-139180
Vancouver
Vago J, Brito LF, Teixeira LCR, Moreira IZ, Miranda TC, Melo EM, Bruno AS, Sugimoto MA, Ferreira RG, Alves Filho JCF, Teixeira MM, Parmer RJ, Miles LA, Sousa LP. The role of plasmin/plasminogen in experimental polymicrobial sepsis [Internet]. Blood. 2020 ; 136 16-17.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2020-139180
Trabalho de evento-resumo periodico
Burden of sickle cell disease: a Brazilian societal perspective analysis (2020)
Pinto, Ana Cristina Silva; Costa, Fernando Ferreira; Gualandro, Sandra Fátima Menosi ; Fonseca, Patricia Belintani Blum; Bueno, Carolina Tosin; Cançado, Rodolfo D.
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidades: FMRP, FM
Subjects: HEMATOLOGIA, ANEMIA FALCIFORME, CUSTOS DOS CUIDADOS DE SAÚDE, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Ana Cristina Silva et al. Burden of sickle cell disease: a Brazilian societal perspective analysis. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2020-136168. Acesso em: 25 fev. 2026. , 2020
APA
Pinto, A. C. S., Costa, F. F., Gualandro, S. F. M., Fonseca, P. B. B., Bueno, C. T., & Cançado, R. D. (2020). Burden of sickle cell disease: a Brazilian societal perspective analysis. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2020-136168
NLM
Pinto ACS, Costa FF, Gualandro SFM, Fonseca PBB, Bueno CT, Cançado RD. Burden of sickle cell disease: a Brazilian societal perspective analysis [Internet]. Blood. 2020 ; 136 10-11.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2020-136168
Vancouver
Pinto ACS, Costa FF, Gualandro SFM, Fonseca PBB, Bueno CT, Cançado RD. Burden of sickle cell disease: a Brazilian societal perspective analysis [Internet]. Blood. 2020 ; 136 10-11.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2020-136168
Trabalho de evento-resumo periodico
Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²) (2020)
Kassim, Adetola A.; de la Fuente, Josu; Alahmari, Ali Debsan; Eckrich, Michael J.; Hanna, Rabi; Dhedin, Nathalie; Horn, Biljana N.; Black, Vandy; Gouveia, Roseane V.; Seber, Adriana; Simões, Belinda Pinto ; Costa, Thalita Cristina de Mello; Cunha, Renato Luiz Guerino
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidade: FMRP
Subjects: TRANSPLANTE DE MEDULA ÓSSEA, HEMATOLOGIA, ANEMIA FALCIFORME
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KASSIM, Adetola A. et al. Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²). Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2020-141771. Acesso em: 25 fev. 2026. , 2020
APA
Kassim, A. A., de la Fuente, J., Alahmari, A. D., Eckrich, M. J., Hanna, R., Dhedin, N., et al. (2020). Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²). Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2020-141771
NLM
Kassim AA, de la Fuente J, Alahmari AD, Eckrich MJ, Hanna R, Dhedin N, Horn BN, Black V, Gouveia RV, Seber A, Simões BP, Costa TC de M, Cunha RLG. Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²) [Internet]. Blood. 2020 ; 136 5 .[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2020-141771
Vancouver
Kassim AA, de la Fuente J, Alahmari AD, Eckrich MJ, Hanna R, Dhedin N, Horn BN, Black V, Gouveia RV, Seber A, Simões BP, Costa TC de M, Cunha RLG. Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²) [Internet]. Blood. 2020 ; 136 5 .[citado 2026 fev. 25 ] Available from: https://doi.org/10.1182/blood-2020-141771

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Non normalized affiliation

Countries of institutions of collaboration